CLABSI Rates Cut with Catheter Maintenance Bundle
The bundle comprises 14 items and has a 5 point checklist to monitor compliance. In this study a quality improvement team from Select Medical developed and implemented a central catheter maintenance bundle for patients admitted to 30 long-term acute care hospitals (LTACHs), whose patients usually arrive with a catheter in place.
The bundle was based on infection prevention guidelines from the Centers for Disease Control and Prevention (CDC), and included compulsory use of alcohol-based central catheter caps and chlorhexidine gluconate dressings. The intervention also included staff education and use of a checklist to track compliance.
See Also: IHI Interventions Prevent Catheter Bloodstream Infections
About 65 percent of patients admitted during the study period had a central catheter. The researchers compared the medical records of 6,660 patients discharged during the 14 months prior to the study and 6,559 patients discharged after implementation of the bundle. The CLABSI standardised infection rate was reduced by 29 percent after implementation of the central catheter maintenance bundle. A mean reduction of 4.5 CLABSIs per hospital occurred for 14 months after implementation of the bundle.
Lead author Antony Grigonis, PhD, Vice President of Quality and Healthcare Analytics at Select Medical, said that the results should encourage other facilities to implement a similar initative, adding: “This infection reduction could also translate to a savings of approximately $3.7 million annually for the 30 Long-Term Acute Care Hospitals studied.”
Source: American Association of Critical-Care Nurses
Image credit: Pixabay
Published on : Mon, 7 Mar 2016
Print as PDF
NovaPort cannulas are designed specially to meet the needs of extracorporeal lung and heart support circuits and perioperative perfusion in minimally invasive heart surgery.All blood-contact surfaces of the NovaPort cannulas are coated with the bio- and...
Monitor vital signs of sensitive patients with reliable, smart and intuitive technology Not available in the US Sensitive patients, like neonates, require comfortable care. With transcutaneous monitoring, you can easily keep track of the oxygenation...
Medos customized tubing sets have been individually designed, so that all customer requirements, depending on application and need can be realized. Furthermore tubing sets can be refined by rheoparin or x.eed coating.
17 critical parameters from a blood sample as small as 45 µL Not available in the US When the sample is small but your diagnostic needs are big, the ABL90 FLEX PLUS blood gas analyzer provides critical insights with a turnaround time of less than...
XENIOS AG is a medical device company with the three brands, novalung, i-cor and medos, that run on a single XENIOS platform. This platform enables next-generation therapies for lung and heart failure. No other company except XENIOS AG is offering lung...